- Injective (INJ) is currently trading at $5.99.
- INJ is expected to trade within a range of $5.66 and $6.24.
- It could result in a potential return on investment of 4.26%.
Injective (INJ) is one of the standout tokens focused on Web3 and interoperability as it approaches its key resistance zone, which has been gaining traction. With improving market sentiment and rising trading activity, traders now await whether INJ can push toward the $8 level in December, potentially setting the stage for a stronger bullish continuation.
Market Outlook: Tracking Trend, Resistance, and Support Levels
Injective (INJ) currently has a market capitalization of approximately $599.71 million, with a trading volume of about $73.29 million in the last 24 hours. At press time, the altcoin is trading at $5.99, having increased by 2.7% over the past 24 hours.
The price is moving in a bullish trend and is currently testing a resistance level near $5.82. If it breaks above this, the next target could be $6.00. On the downside, the support level is around $5.19. If the altcoin falls below this level, we might see a drop towards $4.00.
The blue line indicates the resistance level at $5.82, while the yellow line represents the support level at $5.19.
Also Read: Injective (INJ) Recovery Potential: Key Levels Point Toward $11.33 Upside
CoinCodex Price Outlook and Short-Term Forecast
According to Coincodex’s current price prediction for Injective (INJ), the price is expected to drop by -1.09% and reach $ 5.76 by January 02, 2026. Based on the INJ forecast, it’s not a good time to buy the altcoin.
As per Coincodex data, the price of INJ is predicted to trend downward in the coming days, dipping as low as $ 5.80 by December 06, 2025. This would represent a -3.19% dip compared to today’s rates.
In 2025, INJ is expected to trade within a range of $5.66 and $6.24, resulting in an average annualized price of $ 5.93. This could result in a potential return on investment of 4.26% compared to the current rates.
Putting it all together, Coincodex’s forecast indicates that Injective will continue to experience some short-term downside pressure. Although the broader 2025 range of $5.66-$6.24 suggests some modest annualized appreciation, the near-term bias is still bearish. With $8 still looming as a key ceiling, it might take a more pronounced shift in market sentiment or new catalysts for INJ to attempt a sustained move higher toward that resistance.
Also Read: Injective Partners with Chainlink to Boost Low-Latency Financial Data
